Revvity to Present at BofA Securities 2024 Health Care Conference
25 Aprile 2024 - 2:00PM
Business Wire
Revvity, Inc. (NYSE: RVTY) will present at the BofA Securities
2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m.
PT in Las Vegas, NV.
Senior Vice President and Chief Financial Officer Max Krakowiak
will provide an update on the Company and its strategic priorities.
To register, click here.
A live audio webcast will be available on the Events section of
the Company’s website at www.revvity.com. A replay of the
presentation will be posted on the Revvity Investor Relations
website after the event and will be available for at least 30
days.
About Revvity At Revvity, “impossible” is inspiration,
and “can’t be done” is a call to action. Revvity provides health
science solutions, technologies, expertise and services that
deliver complete workflows from discovery to development, and
diagnosis to cure. Revvity is revolutionizing what’s possible in
healthcare, with specialized focus areas in translational
multi-omics technologies, biomarker identification, imaging,
prediction, screening, detection and diagnosis, informatics and
more.
With 2023 revenue of more than $2.7 billion and over 11,000
employees, Revvity serves customers across pharmaceutical and
biotech, diagnostic labs, academia and governments. It is part of
the S&P 500 index and has customers in more than 190
countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube,
Facebook and Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240425504435/en/
Investor Relations: Steve Willoughby
steve.willoughby@revvity.com
Media Relations: Chet Murray (781) 663-5719
chet.murray@revvity.com
Grafico Azioni Revvity (NYSE:RVTY)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Revvity (NYSE:RVTY)
Storico
Da Dic 2023 a Dic 2024
